# FDA recall Z-0947-2022

> **Matrix Medical Network** · Class II · device recall initiated 2022-01-24.

## Product

Matrix Clinical Solution At-Home COVID-19 Test

## Reason for recall

Due to COVID-19 Test not being authorized for home sample collection.

## Distribution

U.S.: AL, AZ, CA, CO, CT, DC, DE, FL, GA, LA, MA, MD, MI, MN, NH, NJ, NY, OH, OK, PA, TN, TX, UT, VA, and WV.  O.U.S.: N/A

## Key facts

- **Recall number:** Z-0947-2022
- **Recalling firm:** Matrix Medical Network
- **Classification:** Class II
- **Product type:** device
- **Status:** Ongoing
- **Initiation date:** 2022-01-24
- **Report date:** 2022-04-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Scottsdale, AZ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0947-2022

## Citation

> AI Analytics. FDA recall Z-0947-2022. Retrieved 2026-09-24 from https://api.ai-analytics.org/recall/Z-0947-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*